Should the NHS invest billions in personalised medicine, or is genomic healthcare a luxury only the wealthy will access?

The NHS is exploring precision medicine tailored to individual genetic profiles, promising better treatments but at significant cost. As the health service faces unprecedented budget pressures, should it pursue this cutting-edge approach or focus resources on proven, universal interventions?

Anoniem stemmen is mogelijk. Registreer voor een profiel en score.